[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

MBOT

MBOT's LIBERTY system gains FDA clearance, sparking investor interest and discussions on robotic surgery advancements. However, concerns linger regarding historical stock performance and the system's current limited application scope.

About MBOT

MBOT refers to Microbot Medical Inc., a company focused on developing robotic surgical devices.

Insights

mbot engagements is up XXXXX% from the previous week.

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX +18%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2025-06-02
1-Year Low: X on 2025-10-31

Engagements by network (24h): Reddit: XX TikTok: XXXXX X: XXXXX YouTube: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XX -XX%
X Month: XXX -XXXX%
X Months: XXXXX -XXXX%
X Year: XXXXXX +97%
1-Year High: XXXXX on 2025-01-08
1-Year Low: X on 2025-10-31

Mentions by network (24h): Reddit: XX TikTok: XX X: XXX YouTube: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning MBOT in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XXX +12%
X Months: XXXXX +36%
X Year: XXXXX +174%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-10-31

The most influential creators that mention MBOT in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@amar_ffm	X	XXXXXX	X	XXXXX
@nicolejosephinedecor	X	XXXXXX	X	XX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XXX% no change
X Months: XXX% +26%
X Year: XXX% +9%
1-Year High: XXX% on 2024-12-13
1-Year Low: XX% on 2025-12-08

Most Supportive Themes:

FDA Clearance and System Launch: (30%) Microbot Medical's LIBERTY Endovascular Robotic System has received FDA clearance and is being prepared for launch, indicating significant progress in the company's product development and market entry.
Investment and Stock Performance: (25%) Discussions around MBOT as a potential investment, with mentions of stock performance, warrants, and positive outlooks, suggest investor interest and confidence in the company's future.
Robotic Surgery Advancements: (20%) The integration of robotic technology in medical procedures, specifically with MBOT's LIBERTY system, highlights innovation in the MedTech sector and its potential to revolutionize surgery.

Most Critical Themes:

Historical Stock Performance Concerns: (15%) Past performance metrics, such as historical stock prices and EPS, are being scrutinized, raising questions about the company's long-term financial trajectory.
Limited Scope of Current Clearance: (10%) While the LIBERTY system has FDA clearance, it is currently limited to peripheral vascular applications, with no clearance for heart or brain procedures.